Identification of the Novel HLA‐B*46:110 Allele Using Nanopore Sequencing
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70732 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 22.04.2026. Verfasst von Hengcong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nanning Institute of Transfusion Medicine, Nanning Blood Center, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Alleles, HLA-B Antigens, Exons, Nanopore Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Fourth-cycle Medical Key Laboratory Construction Project of Nanning City, Guangxi Natural Science Foundation, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
HLA‐B*46:110 differs from HLA‐B*46:01:01:01 by a nonsynonymous change in codon 53, changing Glutamic acid to Lysine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanning Institute of Transfusion Medicine, Nanning Blood Center, Nanning, Guangxi, China.
ORCID-Profile: Hengcong Li
Förderung
- Fourth-cycle Medical Key Laboratory Construction Project of Nanning City
- Guangxi Natural Science Foundation
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Li, H., Li, L., Chen, Y., Mo, H., & Huang, Y. (2026). Identification of the Novel HLA‐B*46:110 Allele Using Nanopore Sequencing. HLA, 107(4). https://doi.org/10.1111/tan.70732
Vancouver
Li H, Li L, Chen Y, Mo H, Huang Y. Identification of the Novel HLA‐B*46:110 Allele Using Nanopore Sequencing. HLA. 2026;107(4). doi:10.1111/tan.70732
BibTeX
@article{Li2026,
author = {Li, Hengcong and Li, Lilan and Chen, Yuxi and Mo, Huihui and Huang, Yuchen},
title = {Identification of the Novel HLA‐B*46:110 Allele Using Nanopore Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70732}
}
EUVIMED